Table 1 Cohort demographics and clinical characteristics at baseline examination

From: Lysosomal genes contribute to Parkinson’s disease near agriculture with high intensity pesticide use

N (%) or Mean ± SD

All Patients (N = 757)

Disease Progression: All Patients (N = 386)

Progression: European Ancestry (N = 320)

Progression: Hispanic Ancestry (N = 66)

Age at diagnosis, years

67.7 ± 10.6

66.2 ± 10.0

67.0 ± 9.6

62.4 ± 10.9

Sex, Male

468 (61.8%)

241 (62.4%)

192 (60.0%)

49 (74.2%)

Ethnicity, Hispanic

138 (18.2%)

66 (17.1%)

0 (0%)

66 (100%)

Race, White

695 (91.8%)

360 (93.3%)

320 (100%)

40 (60.6%)

PD duration at diagnosis, years

2.9 ± 2.5

2.8 ± 2.4

2.6 ± 2.4

3.5 ± 2.6

Levodopa Use (yes)

530 (70.0%)

269 (69.7%)

226 (70.6%)

43 (65.2%)

LED, mg/day

311 ± 289

290 ± 277

296 ± 284

269 ± 239

UPDRS-III

21.5 ± 11.4

20.1 ± 10.6

18.9 ± 9.9

25.8 ± 12.1

 Rigidity

3.5 ± 2.5

3.4 ± 2.5

3.2 ± 2.3

4.3 ± 3.0

 Bradykinesia

1.1 ± 0.9

1.0 ± 0.8

0.9 ± 0.8

1.5 ± 0.9

 Tremor

3.1 ± 2.6

3.1 ± 2.5

3.0 ± 2.4

3.3 ± 2.7

 PIGD

1.7 ± 1.6

1.4 ± 1.3

1.3 ± 1.3

1.8 ± 1.5

HY (mean)

2.1 ± 0.8

2.0 ± 0.7

1.9 ± 0.7

2.2 ± 0.7

  1. HY Hoehn and Yahr scale, LED Levodopa, PD Parkinson’s disease, PIGD Postural Instability and Gait Difficulties, UPDRS-III Movement Disorder Society-Unified Parkinson’s Disease Rating Scale version III.